{
  "timestamp": "2025-04-19 14:49:45",
  "phase": "Initial Generation",
  "round": 1,
  "elo_score": null,
  "content": "Chemotherapeutic agents inducing DSBs can paradoxically promote secondary neoplasms in survivors by causing mutations in non-target cells.  \n*Supporting evidence:* Secondary malignancies arise after DNA-damaging therapies [Morton 2014, Blood; \"Second cancers after chemotherapy and radiotherapy\"].\n\n---"
}